by qfrsolutions | Apr 4, 2016 | News
Source: PR Newswire FORT WORTH, Texas, [April 4, 2016] – Galderma, a global leader in medical solutions for skin health, and Mentor Worldwide LLC, a global leader in breast aesthetics and reconstruction, today announced a new nationwide collaboration to partner with...
by qfrsolutions | Mar 30, 2016 | News
Source: The Wall Street Journal By AUSTEN HUFFORD Updated March 30, 2016 11:45 a.m. ET Valeant Pharmaceuticals International Inc. sought some room to maneuver Wednesday, asking its lenders to relax some debt-covenant terms and give it an additional month to file its...
by qfrsolutions | Mar 1, 2016 | News
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that data from its Phase 3 pivotal studies of investigational drug crisaborole topical ointment, 2% will be presented at the 74th Annual Meeting of the American Academy of Dermatology in Washington, D.C....
by qfrsolutions | Jan 12, 2016 | News
Source: BioSpace Almirall acquired a minority stake in US based company ThermiGen LLC and plans to close the complete acquisition of ThermiGen by January 31st, 2016. First step towards building a presence in the aesthetics market that helps to further consolidate its...
by qfrsolutions | Jan 8, 2016 | News
Source: Anacor Pharmaceuticals, Inc. (ANAC) announced today that it will present data from the long-term safety study of crisaborole topical ointment, 2% in children and adults with mild-to-moderate atopic dermatitis at the Winter Clinical Dermatology Conference,...
by qfrsolutions | Jan 6, 2016 | News
Source: USA Today Valeant Pharmaceuticals International, the Canadian drugmaker whose CEO has been on medical leave while it faces congressional scrutiny over its pricing practices, said Wednesday it appointed Howard B. Schiller as interim CEO, effective immediately....
